Key result
Fenoldopam is a selective dopamine-1 receptor agonist that produces vasodilation, increases renal blood flow, and improves renal function in animal models of renal failure.
Population
Animals with spontaneous or drug-induced renal failure (and general pharmacological description)
Design
Review
Authors
Loading...
Hypothesis-generating for fenoldopam in hypertensive renal disease; requires randomized human trials before any practice consideration.
Fenoldopam is a selective DA1 receptor agonist that lowers blood pressure while maintaining or improving renal perfusion and function.
Nichols et al. (1990) reported a review. Fenoldopam was evaluated. Fenoldopam is a selective dopamine-1 receptor agonist that produces vasodilation, increases renal blood flow, and improves renal function in animal models of renal failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: